Keywords: robust, 1st, qtr, novo, nordisk, denmark, first-quarter
"Robust" 1st qtr for Novo Nordisk
Article | 05 May 2000
Denmark's Novo Nordisk had a "robust" first-quarter 2000, commentanalysts at Goldman Sachs, who rate the company as a market outperformer. The ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
